Cited by 41Genetic Associations and EpidemiologyTreatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Common variants on 6q16.2, 12q24.31 and 16p13.3 are associated with major depressive disorder

Open access
the 23andMe Research Team7, Li, Xiaoyan, Luo, Zhenwu, Gu, Chunjie, Hall, Lynsey S., McIntosh, Andrew M., Zeng, Yanni, Porteous, David J +5 more·2018·Neuropsychopharmacology

Abstract

Accumulating evidence suggests that genetic factors have a role in major depressive disorder (MDD). However, only limited MDD risk loci have been identified so far. Here we perform a meta-analysis (a total of 90,150 MDD cases and 246,603 controls) through combing three genome-wide association studies of MDD, including 23andMe (cases were self-reported with a clinical diagnosis or treatment of depression), CONVERGE (cases were diagnosed using the Composite International Diagnostic Interview) and PGC (cases were diagnosed using direct structured diagnostic interview (by trained interviewers) or clinician-administered DSM-IV checklists). Genetic variants from two previously unreported loci (rs10457592 on 6q16.2 and rs2004910 on 12q24.31) showed significant associations with MDD (P < 5 × 10-8) in a total of 336,753 subjects. SNPs (a total of 171) with a P < 1 × 10-7 in the meta-analysis were further replicated in an independent sample (GS:SFHS, 2,659 MDD cases (diagnosed with DSM-IV) and 17,237 controls) and one additional risk locus (rs3785234 on 16p13.3, P = 1.57 × 10-8) was identified in the combined samples (a total of 92,809 cases and 263,840 controls). Risk variants on the identified risk loci were associated with gene expression in human brain tissues and mRNA expression analysis showed that FBXL4 and RSRC1 were significantly upregulated in brains of MDD cases compared with controls, suggesting that genetic variants may confer risk of MDD through regulating the expression of these two genes. Our study identified three novel risk loci (6q16.2, 12q24.31, and 16p13.3) for MDD and suggested that FBXL4 and RSRC1 may play a role in MDD. Further functional characterization of the identified risk genes may provide new insights for MDD pathogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41386-018-0078-9

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The gene encoding P2X7R is located in a susceptibility locus of relevance to depression in humans.

    “which corroborates the findings that the gene encoding for the P2X7R is located in a susceptibility locus of relevance to depression in humans.”

    From P2X7 Receptor Signaling in Stress and Depression (2019) · cites this paper as [70]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 62 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. Ripke S, Wray NR, Lewis CM, Hamilton SP, Weissman MM, Breen G, et al. A mega- analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry. 2012;18:497-511.
  2. The Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium (2018). Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depressive disorder. BioRxiv preprint first posted online Jul 24, 2017 doi: 101101/167577.

Cited by

Sorted by citations

Authors
Team7, T. 2. R., Li, X., Luo, Z., Gu, C., Hall, L. S., McIntosh, A. M., Zeng, Y., Porteous, D. J., Hayward, C., Li, M., Yao, Y.-G., Zhang, C., & Luo, X.-J.
Affiliations
  • Kunming Institute of Zoology (CN)
  • Medical University of South Carolina (US)
  • University of Edinburgh (GB)
  • Institute of Genetics and Cancer (GB)
  • Western General Hospital (GB)
  • Shanghai Jiao Tong University (CN)
Corresponding author
  • Zhang, Chen
  • Luo, Xiong-Jian
Venue
Neuropsychopharmacology
Published
2018-04-27
Volume
43
Issue
10
Pages
2146-2153
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W2801366487
Cited by
41
References
62
Citations by year
2026: 2 · 2025: 4 · 2023: 5 · 2022: 4 · 2021: 13 · 2020: 4 · 2019: 9
FWCI
3.99
Type
journal article
Language
en
Open access
Locations
  • Neuropsychopharmacology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
Funders
  • Wellcome Trust (104036/Z/14/Z)
  • Scottish Government (CZD/16/6)
  • Scottish Funding Council (HR03006)
  • National Natural Science Foundation of China (2016YFA0100900, 81,471,358, 31722029, 81671326)
  • Chinese Academy of Sciences (XDB13000000, 2016YFA0100900)
  • Chief Scientist Office, Scottish Government Health and Social Care Directorate (CZD/16/6)
  • Medical Research Council (104036/Z/14/Z, MR/K026992/1, MC_UU_00007/10)
  • National Key Research and Development Program of China (81471358, 2016YFA0100900)
  • National Key Research and Development Program of China Stem Cell and Translational Research (2016YFA0100900)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
major depressive disorder, genetic susceptibility loci, 16p13.3, FBXL4, single nucleotide polymorphisms, brain gene expression, neurogenomics, depression pathogenesis
MeSH terms
Brain Chemistry, Chromosomes, Human, Major Depressive Disorder, Humans, Nuclear Proteins, Genetic Variation, Gene Expression, Risk Assessment, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Diagnostic and Statistical Manual of Mental Disorders, Ubiquitin-Protein Ligases, F-Box Proteins, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review